Apnoea after THAM administration in the newborn. The use of THAM in the treatment of neonatal acidaemia is surveyed over a 3-year period. Of 100 babies to whom the drug was given while they were breathing spontaneously, 17% had respiratory depression during, or within two minutes of injection. If only potentially viable babies are considered, the incidence of respiratory depression increases to 20% and the incidence in babies with respiratory distress is 17%. No single group of babies was particularly susceptible to this action of THAM, except those who had had a previous spontaneous apnoeic attack. No babies became apnoeic after the injection of sodium bicarbonate. It appears that in the 'good prognosis' group according to the hyperoxia test those babies who require correction of their pH have a higher death rate than those who do not. There was no statistically significant increase in the death rate of babies who deteriorated after THAM, but several of these babies only survived after treatment with artificial ventilation. There was an increased incidence of intraventricular haemorrhage in those babies who received 700 THAM rather than 3 60% THAM, but this may be due to other factors in their illness.
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The respiratory distress syndrome (RDS) in the newborn baby is characterized by the clinical triad of tachypnoea, expiratory grunting, and inspiratory retraction (Rudolph and Smith, 1960) . Such babies have a combined respiratory and metabolic acidosis (Oppe, Priestley, and Redstone, 1965) , and their routine care now includes correction of the pH with either sodium bicarbonate or tris (hydroxymethyl) aminomethane (THAM, trometamol) (Troelstra et al., 1964; Gupta, Dahlenburg, and Davis, 1967; Usher, 1963; Hutchison et al., 1964) . In the presence of pulmonary disease THAM has a theoretical superiority over sodium bicarbonate, which requires an open system to be an effective buffer. THAM reacts directly with dissolved CO2 in the plasma forming a cation (excreted in the urine), and liberates one bicarbonate ion in the process without adding sodium ions to the circulation ( Fig.) (Nahas, 1963; Strauss, 1968) .
During recent years it has been our policy on the .
Results
One hundred babies were given THAM when breathing spontaneously, and 17 developed significant respiratory depression (Table I) ; 2 of the 17 had cardiac arrests. 35 survived the neonatal period: 4 who became apnoeic (including both babies who had cardiac arrests) and 31 who did not. If we exclude non-viable babies, i.e. all babies of less than 1000 g. birthweight and less than 28 weeks' gestation, and babies with major congenital malformations such as meningomyelocele and Potter's syndrome, 74 babies (including all survivors) received THAM and 15 became apnoeic. 65 of these 74 babies fulfilled our criteria for RDS at 4 hours of age Reynolds, Roberton, and Wigglesworth, 1968) Hg have a mortality of about 25%; those who cannot have mortality of about 75%. These data *Two of these babies also had an intraventricular haemorrhage, and were available on 43 out of 65 babies. Table IV one of them was the baby dying at 6 weeks.
shows that there is no obvious difference in the prognosis on the hyperoxia test of the four groups of babies shown. In particular there is no difference in prognosis assessed by the hyperoxia test between the group of babies who tolerated THAM and those who did not; there were more 'good' prognosis babies in the group who deteriorated after THAM. The blood gas tensions immediately before the drug was injected were very similar both in those babies who tolerated the drug and in those who did not (Table V) . (2) Incidence of previous apnoeic attacks. There was a significantly greater incidence of spontaneous apnoeic attacks in those babies who became apnoeic after THAM compared with those babies who tolerated the drug (Table VI) . All 6 babies who had had spontaneous apnoeic attacks, but who tolerated THAM, survived the neonatal period, though one did die at 6 weeks of age from the effects of tracheal stenosis acquired during prolonged intubation and IPPR. However, of the 6 babies who had had spontaneous apnoeic attacks but who did not tolerate THAM 4 died. The apnoeic attacks that occurred spontaneously were presumably more severe in the babies who had tolerated THAM than in those babies who had not, since all 6 in the first group required IPPR (4) Death rate. It is important to assess whether the death rate in babies becoming apnoeic after THAM is higher than in babies who tolerated the drug. In Table I it can be seen that the (5) Birthweight (Table IX) ; (6) Gestational age (Table IX) ; (7) Route of injection (Table X) ; (8) Age of baby in hours when drug injected (Table  XI) ; (9) Total Volume of drug administered during the illness (Table XII) ; (10) Volume of each injection (Table XIII) ; (11) Blood gas tensions (PaO2, pH, and Paco2) immediately before drug injected (Table V) ; (12) Strength of Injection (3-6% or 7-0%) (Table XIV); and (13) IVH rate (Table XV) . In particular, the means of the blood gas tensions immediately preceding the injection of THAM were very similar (Table V) .
If we compare the above parameters in babies who received sodium bicarbonate, against all babies receiving THAM, there was no significant difference between the two groups for parameters 3 to 10 inclusive, apart from larger volumes of bicarbonate being given at each injection (Table  XIII) x2 (for THAM tolerated versus NaHCO3 using Yates' correction) = 7-56; 0-001 < p < 0-01 x2 (for THAM tolerated versus apnoea after THAM, using Yates' correction) = 0 05; 0 9 < p < 0-8 NS. The physical characteristics of the solutions injected seems unlikely to be important in the aetiology of the apnoea, or of the IVH. The THAM solutions were either 0 3 molar or 0-58 molar, but the sodium bicarbonate solutions were usually twice molar-much more hypertonic than the THAM solutions. Bearing in mind the dangers of intravenous hyperosmolar solutions, which include intracerebral haemorrhage, and of exceeding an infusion rate of 25 mOsm./kg. body water/4 hours (Finberg, 1967) , we found 2 babies out of the 65 who exceeded this. At the time of receiving the osmolar load, both the babies were already apnoeic and being artificially ventilated. The most significant feature was that the majority of the osmoles administered to these babies were in the form of sodium bicarbonate-yet neither apnoea nor IVH seemed to be a feature of sodium bicarbonate being given to other babies. One of these babies had an IVH. Discussion THAM has three majortheoretical advantages over sodium bicarbonate: it is capable of correcting a hypercapnic acidosis directly; it is just as efficient at correcting a metabolic acidosis (Ligou and Nahas, 1960; Nahas, 1963) in the extracellular fluid and more efficient at correcting CSF pH, and the intracellular component of a metabolic acidosis (Robin, Wilson, and Bromberg, 1961; Holmdahl et al., 1961) ; and it achieves these actions without adding sodium ions to the circulation. Some workers, however, have shown that sodium bicarbonate corrects intracellular pH just as effectively as THAM (Adler, Roy, and Relman, 1965) , or even better (Irvine and Dow, 1966) . Rapid correction of intracellular and CSF pH is not necessarily beneficial. It has been suggested that the apnoea which followed THAM administration in hypercapnic acidosis is due to the too rapid correction of the pH around and within the respiratory centre, thereby decreasing the drive to inspiration (Katz et al., 1963) . THAM is known in experimental animals and adult man to be very effective at correcting a hypercapnic acidosis by increasing the pH and bicarbonate and lowering the PaCo2 (Brown et al., 1961; Epstein, Nahas, and Mark, 1961) . In normal adult human volunteers (Berman, O'Connor, and Luchsinger, 1960) and in adult humans in respiratory failure with a raised Paco2, THAM definitely causes respiratory depression (Luchsinger, 1961; Swanson, 1960 (Adamson et al., 1968 ). In the babies described by Gupta et al. (1967) , the Paco2 values improved concurrently with the pH and Pao2 after injection of THAM, presumably due to improvement in pulmonary perfusion, and correction of the respiratory acidosis at source.
The problem of a sodium load does not seem to arise in practice. In our babies it is only in the full-term babies who have RDS mimicking cyanotic congenital heart disease (Roberton, Hallidie-Smith, and Davis, 1967 ) that heart failure requiring and benefiting from digoxin is seen, and these babies usually need very little correction of acidaemia. No baby described in the present paper who received sodium bicarbonate developed heart failure.
THAM is also known to increase the serum potassium (Epstein et al., 1961) , and though this was not measured routinely it may have played a part in the two cardiac arrests that occurred during THAM administration to our babies. The known metabolic effect of THAM to lower the blood glucose (Bennett and Tarail, 1961) was not detected. We have not seen any cases of liver necrosis (Goldenberg, Wiegenstein, and Hopkins, 1968; Nahas, 1968) .
In this series respiratory depression coincident with THAM administration took place in 17 out of 100 babies treated at Hammersmith Hospital in the years 1965--1967. The series described by Gupta et al. (1967) (Bergofsky et al., 1961) , though it will improve the pulmonary hypertension of acidaemia from any cause (Ligou et al., 1961) . It has recently been shown that similar dramatic responses to those seen by Gupta et al. (1967) after THAM have followed sodium bicarbonate administration (Russell and Cotton, 1968) . One can draw no meaningful comparisons of death and IVH rates between the babies with RDS receiving THAM or sodium bicarbonate, as the two groups of babies were very different in terms of their prognosis on blood gas tensions at 6 hours of age, and their physiological derangement when alkali was injected. However, no baby deteriorated after injection of sodium bicarbonate, and in fact apnoea is not a recognized complication of its administration.
Conclusions
The incidence of respiratory depression of 17°% after administration of THAM to babies with RDS suggests that the use of this drug to correct acidaemia in neonatal respiratory failure should be reevaluated, comparing it with the use of sodium bicarbonate in a control series, and, meanwhile, THAM should be used only in hospital units with facilities for prolonged mechanical ventilation of the newborn. (Of the 3 out of the 11 babies with RDS who survived THAM-induced apnoea, 2 required artificial ventilation for many hours.) It is important to realize that the respiratory depressant action of THAM is not limited to babies with RDS. 4 of the 9 babies listed in Table  II , who were suffering from other disease processes, also become apnoeic after its administration.
THAM may still have a place in the management of certain respiratory problems in the neonate. In the rare baby who is being artificially ventilated without satisfactory control of the PaCO2, THAM appears to be the drug of choice. THAM may also be preferable in the resuscitation of the asphyxiated newborn where IPPR is being used. The rapid correction of intracellular pH within the respiratory centre may initiate gasping and then regular respiration which had not previously been possible in the presence of a severe depression of the extracellular, intracellular, and CSF pH (Dawes, 1968) .
The fact that equimolar doses of THAM are less effective buffers at body pH than doses of sodium bicarbonate (Nahas, 1963; Bleich and Schwartz, 1966) ; the fact that these more dilute solutions of THAM probably cause more apnoea; the fact that THAM may cause more IVH; and the fact that the more concentrated solutions of sodium bicarbonate seem to be well tolerated, suggest that sodium bicarbonate may well prove to be the base of choice in the routine treatnent of acidaemia in the newborn baby with RDS.
Though the superiority of sodium bicarbonate is not conclusively proved in this study, there is a case for carrying out a carefully controlled trial of the use of the two agents in the respiratory distress syndrome.
